Advertisement
Screener

Lineage Cell Therapeutics, Inc. (LCTX) Form D

Lineage Cell Therapeutics, Inc. Form D Notices of Exempt Offering of Securities

Notices filed with the SEC for securities sold without registration under Regulation D or Section 4(a)(5), newest first. Values are as filed.

  • 2011-02-02: Federal exemption Rule 505; Rule 506; Types of securities offered Equity; Date of first sale 2011-01-28; Total offering amount $2,300,000.
  • 2010-05-21: Federal exemption Rule 506; Types of securities offered Equity; Date of first sale 2010-05-07; Total offering amount $8,000,000.
  • 2010-05-05: Federal exemption Rule 505; Rule 506; Types of securities offered Equity; Date of first sale 2010-04-27; Total offering amount $61,220.
FiledFederal exemptionTypes of securities offeredDate of first saleTotal offering amountTotal amount soldTotal remaining to be soldInvestors who have already invested
2011-02-02Rule 505; Rule 506Equity2011-01-28$2,300,000$2,300,000$08
2010-05-21Rule 506Equity2010-05-07$8,000,000$8,000,000$02
2010-05-05Rule 505; Rule 506Equity2010-04-27$61,220$61,220$03

Similar stocks

Stock NameCountryMarket CapPE Ratio
Aligos Therapeutics, Inc. (ALGS)United States$0.238B-0.47
SUTRO BIOPHARMA, INC. (STRO)United States$0.260B-3.05
Protalix BioTherapeutics, Inc. (PLX)$0.221B9.87
ANAVEX LIFE SCIENCES CORP. (AVXL)United States$0.218B-18.37
Alector, Inc. (ALEC)United States$0.213B-1.90
Invivyd, Inc. (IVVD)United States$0.270B-2.42
PALISADE BIO, INC. (PALI)United States$0.275B-11.41
Compass Therapeutics, Inc. (CMPX)United States$0.204B-5.35
Lexeo Therapeutics, Inc. (LXEO)United States$0.278B-4.19
FATE THERAPEUTICS INC (FATE)United States$0.280B-2.51